antibiotics

News

One in six common bacterial infections in people worldwide in 2023 were resistant to antibiotic treatments, according to the WHO.

R&D

Exploring the growing threat of UTIs, the need for new antibiotics, and GSK’s role in advancing targeted treatments.

News

Iterum has launched Orlynvah as a treatment for uncomplicated urinary tract infections (uUTIs), the first oral option in the go-to penem class.

News

Generative artificial intelligence could hold the key to turning back the rising tide of antimicrobial resistance, say MIT researchers.

News

An oral alternative to injectable treatment for uncomplicated gonorrhoea could be on the way in the US, as FDA starts review of GSK's gepotidacin.

R&D

AMR demands sustained commitment beyond conventional market incentives.